Related Experiment Video
Updated: Feb 3, 2026
Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction
Published on: February 24, 2014
Purification of Capsular Polysaccharides of Streptococcus pneumoniae: Traditional and New Methods
Victor Morais1, Valerie Dee1, Norma Suárez1
1Department of Biotechnology, Institute of Hygiene, Faculty of Medicine, University of the Republic, Montevideo, Uruguay.
Insights
Purifying capsular polysaccharide (CPS) from Streptococcus pneumoniae is crucial for developing effective vaccines. Current methods aim to improve quality, yield, and simplify the process for this major bacterial pneumonia cause.
Area of Science:
- Microbiology
- Vaccinology
- Biotechnology
Background:
- Streptococcus pneumoniae causes significant global mortality, especially in young children and older adults.
- The bacterial capsular polysaccharide (CPS) is a key virulence factor and essential target for vaccine development.
- Current S. pneumoniae vaccines are effective but costly, necessitating improved production methods.
Purpose of the Study:
- To review existing methods for capsular polysaccharide (CPS) purification from Streptococcus pneumoniae.
- To highlight advancements in CPS purification techniques.
- To identify strategies for enhancing purification quality, yield, and process simplification.
Main Methods:
- Literature review of published studies on CPS purification techniques.
- Analysis of different purification strategies, including those using CPS alone or conjugated to proteins.
- Evaluation of methods focusing on yield, purity, and scalability.
Main Results:
- Various methods for CPS purification are currently available.
- Advances focus on optimizing CPS quality and extraction yield.
- Simplification of the purification process is a key objective for cost-effective vaccine production.
Conclusions:
- Efficient CPS purification is vital for the development of affordable and accessible Streptococcus pneumoniae vaccines.
- Ongoing research aims to refine purification processes for better yield and quality.
- Streamlined purification methods could reduce vaccine costs and improve global health outcomes.
Abstract:
Pneumonia caused by Streptococcus pneumoniae is a major bacterial disease responsible for many deaths worldwide each year and is particularly dangerous in children under 5 years old and adults over 50. The capsular polysaccharide (CPS) constitutes the outermost layer of the bacterial cell and is the main virulence factor. Regardless of whether pharmaceutical agents are composed of CPS alone or protein-conjugated CPS, CPS purification is essential for the development of vaccines against S. pneumoniae. These vaccines are effective and safe but remain quite expensive. This review describes the methods currently available for CPS purification. Advances in CPS purification methods are aimed at improvements in quality and yield and, above all, process simplification.
Related Concept Videos
01:14Decision Making: Traditional Method
First, a specific claim about the population parameter is decided based on the research question and is stated in a simple form. Further, an opposing statement to this claim is also stated. These statements can act as null and alternative hypotheses, out of which a null hypothesis would be a...
01:26Biosynthesis of Polysaccharides
01:15Cellulose and Pectic Polysaccharides
As a cell matures, its cell wall specializes according to its type. For example, the...
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia II: Pathophysiology
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: